Issue 79, 2023

Gd/hafnium oxide@gold@chitosan core–shell nanoparticles as a platform for multimodal theranostics in oncology research

Abstract

In the current study, we synthesized thiolated chitosan-stabilized gold-coated, gadolinium-doped hafnium oxide nanoparticles (CAuGH NPs) with the capability of acting as a multifunctional system to deliver anticancer drug doxorubicin (DOX), to enhance radiosensitization by ROS generation, and to provide magnetic resonance (MR) imaging contrast for biomedical applications.

Graphical abstract: Gd/hafnium oxide@gold@chitosan core–shell nanoparticles as a platform for multimodal theranostics in oncology research

Supplementary files

Article information

Article type
Communication
Submitted
21 Jun 2023
Accepted
11 Sep 2023
First published
11 Sep 2023

Chem. Commun., 2023,59, 11819-11822

Gd/hafnium oxide@gold@chitosan core–shell nanoparticles as a platform for multimodal theranostics in oncology research

A. Gupta, R. Singhmar, A. Sood, D. Bhardwaj, S. S. Kumaran, S. Chaturvedi and G. Agrawal, Chem. Commun., 2023, 59, 11819 DOI: 10.1039/D3CC02971A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements